Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Two Part Placebo-Controlled Study Consisting of a Single Ascending and Multiple-Dose Tolerance Study of Peroral Insulin in Patients With Type 2 Diabetes

NCT00990444 is registered in ClinicalTrials.gov with Bows Pharmaceuticals AG as lead sponsor.

NCT NCT00990444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00990444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Two Part Placebo-Controlled Study Consisting of a Single Ascending and Multiple-Dose Tolerance Study of Peroral Insulin in Patients With Type 2 Diabetes
Lead sponsor
Bows Pharmaceuticals AG
Phase
Phase 1/2
Overall status
Suspended
Start date
September 30, 2009
Completion date
December 31, 2010
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus